News

Arrowhead Pharmaceuticals' Exciting December 2024 Conference Lineup

Arrowhead Pharmaceuticals' Exciting December 2024 Conference Lineup

Arrowhead Pharmaceuticals to Engage at December Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has exciting participations lined up for December 2024. With several key conferences approaching, Arrowhead aims to showcase its innovative advancements in RNA-based therapeutics and engage with healthcare professionals and stakeholders in the industry.

Key Conferences and Participation

Among the notable events is the Piper Sandler 36th Annual Healthcare Conference scheduled for December 3-5, 2024. This platform will feature a fireside chat presentation on December 3 at 1:30 p.m. EST, making it an excellent opportunity for discussions on future healthcare innovations.

Evercore ISI HealthCONx Conference

Simultaneously, Arrowhead will present at the 7th Annual Evercore ISI HealthCONx Conference from December 3-5, 2024. The firm is set to host another fireside chat, this time on December 4 at 2:10 p.m. EST.

Scientific Contributions at Noteworthy Meetings

A crucial aspect of Arrowhead’s agenda is the participation in the APA/JPS/CAP 2024 Joint Meeting from December 9-12. Here, they will present on the PALISADE Phase 3 study assessing the efficacy and safety of Plozasiran for adults with genetically or clinically-defined Familial Chylomicronemia Syndrome. This significant study discusses risks associated with acute pancreatitis and takes place on December 9 at 12:00 p.m. HST.

Further Connections in RNA Therapeutics

In addition to these events, Arrowhead Pharmaceuticals will be part of the RNA at the Bench and Bedside IV conference during the same dates. Their presentation titled "Developing siRNA for Neurodegenerative Disorders" is scheduled for December 9 at 2:10 p.m. PST, featuring insights into pre-clinical RNA therapeutics.

Global CVCT Forum

The 21st Global CVCT Forum running from December 9-11 will also host Arrowhead's discussions on a randomized, placebo-controlled Phase 3 study of Plozasiran in patients with Familial Chylomicronemia Syndrome. Arrowhead expects to engage closely with peers and other stakeholders on December 10 at 7:30 p.m. EST.

Complement-Based Drug Development Summit

The 8th Complement-Based Drug Development Summit is another key event slated for December 10-11. Arrowhead will delve deeper into therapies targeting complement C3 and Factor B, providing a session on December 11 at 10:00 a.m. EST, assessing advances in complement therapies.

Expanding Presence at the WCIRDC

Furthermore, Arrowhead will join the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) from December 12-14. They will revisit the PALISADE study on December 13 from 7:30-9:00 a.m. PST, showcasing their commitment to innovative research in cardiovascular diseases.

Accessing Presentation Materials

All presentation materials from these upcoming events will be made available for access on Arrowhead's 'Events and Presentations' webpage within their Investors section, ensuring stakeholders can review insights shared during the conferences.

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is dedicated to developing medicines targeting hard-to-treat diseases by silencing genes responsible for these conditions. Their robust portfolio utilizes various RNA chemistries, embracing efficient delivery systems to activate the RNA interference process effectively. Through innovative approaches, Arrowhead facilitates prompt and lasting knockdown of target genes, harnessing the RNAi mechanism inherent to living cells to inhibit specific gene expressions impacting protein production.

To stay current with developments from Arrowhead, visit their official website or follow them across various social media platforms including X (formerly Twitter), LinkedIn, Facebook, and Instagram.

Frequently Asked Questions

What is the significance of Arrowhead's upcoming conferences?

These conferences provide Arrowhead with a platform to showcase their latest research and collaborate with industry professionals.

Who will represent Arrowhead at these events?

Key personnel including Eleonora Goldberg, Christine Esau, Jennifer Hellawell, Robert Rosenson, James Hamilton, Nick Leeper, and Ira Goldberg will be presenting at various sessions.

What are the main focus areas of the presentations?

Presentations will focus on RNA-based therapies and studies related to Familial Chylomicronemia Syndrome, alongside advancements in complement-based therapies.

Where can I find the presentation materials?

Presentation materials will be accessible on Arrowhead’s 'Events and Presentations' page under the Investors section of their website.

How does Arrowhead utilize RNA interference?

Arrowhead uses RNA interference to silence problematic genes responsible for various diseases, impacting protein production and harboring the potential for therapeutic advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading

Top 5 Most Recently Viewed Articles

KORE Group Holdings Reports Strong Performance in Q3 2025

Updated Category News Views 214

KORE Group Holdings Delivers Impressive Q3 Financial Results KORE Group Holdings, Inc. (NYSE: KORE), a prominent player in the Internet of Things (IoT) sector, has reported resilient financial performance for the third quarter of 2025. The company has demonstrated commendable growth in key metrics such as adjusted EBITDA, connections, and free cash flow, while also...

Continue Reading
Hot Chili Limited Secures Funds Through Successful Entitlement Offer

Updated Category News Views 133

Hot Chili Limited Announces Fully Subscribed Entitlement Offer Hot Chili Limited (TSXV: HCH, OTC: HHLKF) has made an impressive mark as it announces the successful completion of its entitlement offer, which was fully subscribed, bringing in A$14.1 million. This strong demand from eligible shareholders across Australia, Canada, and other international markets showcases...

Continue Reading
Innovative Partnership between Henkel and Sasol for Sustainability

Updated Category News Views 381

Driving Sustainability in Consumer Goods The collaboration between Henkel and Sasol represents a significant step toward enhancing sustainability in the consumer goods market. By leveraging Sasol's cutting-edge wax innovations, reductions in carbon emissions are being achieved throughout Henkel's adhesive value chain, paving the way for a more eco-friendly future....

Continue Reading
Navigating Risk Management Challenges in the Banking Sector

Updated Category News Views 548

Understanding the Current Landscape of Risk Management in Banking In recent findings from the Wolters Kluwer Regulatory & Risk Management Indicator survey, there's a notable shift in the concerns of the U.S. banking industry. Approximately half of the respondents reported elevated levels of concern regarding risk management and regulatory compliance efforts. Survey...

Continue Reading
Canton Fair Highlights Innovation in Manufacturing Technologies

Updated Category News Views 165

Showcasing the Future of Intelligent Manufacturing GUANGZHOU, China – The China Import and Export Fair, commonly known as the Canton Fair, has established itself as a pivotal platform for the global manufacturing sector to unveil transformative technologies and promote industrial progress. This prestigious event exhibits the latest innovations in automation, robotics,...

Continue Reading